I-Corps: A Multi-Antigen Vaccine Delivery System for the Effective Induction of Mucosal Im — NSF Award to Cornell University (NY,
The broader impact/commercial potential of this I-Corps project is the development of a novel vaccine discovery platform. The COVID-19 pandemic has opened our eyes to the urgent need for technologies capable of effectively delivering vaccines that combat mucosal infections. Mucosal infections, such as influenza and rot
| Award title | I-Corps: A Multi-Antigen Vaccine Delivery System for the Effective Induction of Mucosal Im |
|---|---|
| Award ID | 2033559 |
| Awardee | Cornell University |
| City | ITHACA |
| State | NY |
| Amount obligated | $50,000 |
| Principal investigator | Tom Schryver |
| Program | I-Corps |
| Start date | 08/01/2020 |
| Abstract | The broader impact/commercial potential of this I-Corps project is the development of a novel vaccine discovery platform. The COVID-19 pandemic has opened our eyes to the urgent need for technologies capable of effectively delivering vaccines that combat mucosal infections. Mucosal infections, such as influenza and rotavirus, make up more than 70% of the yearly cases of infectious diseases recorded in the US, and more than 50% of all infections worldwide. This high infection rate is because most |
| Source | NSF Awards |
$799/mo
Try NSFGrants →